Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 1

1(25.0%)

4Total

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05206981Recruiting

Device Global Registry for the IlluminOss Bone Stabilization System

Role: lead

NCT04842266Recruiting

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

Role: collaborator

NCT02338492Not ApplicableCompleted

Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus

Role: lead

NCT02373904Not ApplicableCompleted

A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease

Role: lead

NCT02394080Not ApplicableUnknown

Safety and Efficacy Study of the Treatment of Humerus Fractures

Role: lead

NCT00823251Phase 1Completed

IlluminOss Hand Fracture International Clinical Feasibility Study

Role: lead

All 6 trials loaded